Healthtech Late Stage Investors & VC Firms
494 firms in this list, with a median first check of $1M. 98 of them lead rounds. Generated from verified public data and updated continuously.
AbCellera
VancouverSeries B–Late Stage
21 people
Endeavour Vision
GenevaLate Stage
6 people
Shepherd Ventures
San DiegoSeries A–Late Stage$750K – $3M
6 people
Wealthing VC Club
Palo AltoSeed–Late Stage
9 people
Partners Investment Co. Ltd.
SeoulSeries A–Late Stage
11 people
Amgen Ventures
Thousand OaksSeed–Late Stage$1M – $3M
2 people
Fresenius Medical Care Ventures
Bad HomburgSeed–Late Stage
7 people
AIMCo private equity
EdmontonGrowth–Late Stage
14 people
BPEA EQT
Growth–Late Stage$50M – $3B
8 people
RH Managers
JohannesburgSeed–Late Stage
14 people
Phoenix Tree Capital Partners
BeijingSeed–Late Stage
9 people
Digital Horizon
George TownPre-Seed–Late Stage
4 people
Access Biotechnology
New YorkSeed–Late Stage
3 people
Avedon Capital Partners
AmsterdamGrowth–Late Stage
5 people
Evidity Health Capital
New YorkGrowth–Late Stage$5M
5 people
IAN Fund
Late Stage
14 people
Rosetta Capital Ltd.
OxfordGrowth–Late Stage
8 people
Avego BioScience Capital
AlpharettaSeries A–Late Stage
2 people
QC·VENTURES
ViennaSeed–Late Stage$216K – $4.3M
7 people
Ardenton Capital Corporation
VancouverGrowth–Late Stage
11 people
CLI Ventures
Palo AltoSeed–Late Stage
6 people
Lingotto
Seed–Late Stage
2 people
Kejora Capital
SingaporeSeed–Late Stage
3 people
Oquirrh Ventures
Salt Lake CityGrowth–Late Stage$10M – $50M
6 people
Related lists
Healthtech Investors & VC Firms (4190)Healthtech Seed Investors & VC Firms (3233)Healthtech Investors & VC Firms in North America (2665)Healthtech Investors & VC Firms in United States (2436)Healthtech Series A Investors & VC Firms (2309)Late Stage Investors & VC Firms (1725)Healthtech Pre-Seed Investors & VC Firms (1468)Healthtech Investors & VC Firms in Europe (1357)Healthtech Growth Investors & VC Firms (1269)Healthtech Investors & VC Firms in Global (1181)
Data sourced from public filings and firms' own websites — see our methodology.











































































